Close

Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. INFY
3. ISRG
4. TSM
5. SPY
6. JWN
7. BX
8. SNV
9. AXP
10. SLB


Go back to Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia
(NASDAQ: KRTX) Delayed: 329.83 --0 (-0%)
Previous Close $329.83    52 Week High $ 
Open $329.83    52 Week Low $ 
Day High $329.83    P/E N/A 
Day Low $329.83    EPS $ 
Volume 2,872